BNP Paribas Financial Markets
SOPH icon

BNP Paribas Financial Markets’s SOPHiA GENETICS SOPH Stock Holding History

BNP Paribas Financial Markets’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-489
Closed -$1.29K – 4555
2022
Q3 		$1.29K Buy
+489
New +$1.71K ﹤0.01% 4401

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets's SOPH Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of SOPHiA GENETICS (SOPH) in Q4 2022, closing a stake of 489 shares — an estimated $1.29K sold.

BNP Paribas Financial Markets first reported a position in SOPH in Q3 2022 and held it in 1 quarter. The position peaked at $1.29K in Q3 2022. 32 funds tracked by Wall St. Rank hold SOPH as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining SOPHiA GENETICS position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 489 SOPHiA GENETICS shares in Q4 2022, an estimated $1.29K.
  • BNP Paribas Financial Markets first reported a position in SOPHiA GENETICS in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's SOPHiA GENETICS position peaked at $1.29K in Q3 2022.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.